Diabetes

The AJMC® Diabetes compendium is a comprehensive resource for clinical news and expert insights for the chronic condition.

Latest News

Rural health sign | Image credit: BJP7images - stock.adobe.com
FQHCs Show Low Engagement in Hypertension, Diabetes Trials

April 15th 2025

A new review finds federally qualified health centers (FQHCs) are underutilized in hypertension and type 2 diabetes clinical research, despite their potential to improve trial diversity.

AI representation of housing stability | Image credit: GoldPumaze - stock.adobe.com
Housing Instability Linked to Worse Type 2 Diabetes Outcomes

April 14th 2025

Diabetes concept | Image credit: Sherry Young - stock.adobe.com
GLP-1 RAs, SGLT2 Inhibitors Associated With Reduced MACE, HHF in Patients With Diabetes

April 9th 2025

AJMC
The Role of Advanced Technologies in Improving Diabetes Outcomes

April 7th 2025

Diabetes - Vitalii Vodolazskyi - stock.adobe.com.jpg
More Than 250 Million Individuals Unaware They Have Diabetes

April 7th 2025

More News

Site Logo
September 30th 2018

AADE Poster Presentations: A Look at Research Presented at the AADE Annual Conference

Mary Caffrey
POSTERS AT THE 2018 American Association of Diabetes Educators (AADE) Annual Conference covered updates on new therapies and technology, strategies to help patients overcome fear of using insulin, and innovations in diabetes self-management education and support. Following are a few snapshots of the research presented at AADE.
Site Logo
September 29th 2018

From the Editor-in-Chief: Technology Is a Great Tool, but the Team Makes the Difference

Robert Gabbay, MD, PhD, FACP
A letter from our Editor-in-Chief, Robert Gabbay, MD, PhD, FACP.
Podcast: This Week in Managed Care—Responding to CMS and Other Health News
September 29th 2018

Podcast: This Week in Managed Care—Responding to CMS and Other Health News

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.
Site Logo
September 28th 2018

From High Tech to Low, Livongo Meets People With Diabetes at Decision Points

Mary Caffrey
Livongo’s technology is built around the idea that a person living with diabetes must make multiple decisions every day, and the cumulative effect of all those decisions drives outcomes.
Site Logo
September 28th 2018

Through "Information Shift" and Support, North Carolina Program Brings Dramatic A1C, Therapy Reductions

Mary Caffrey
A profile of a program that calls for residents in a rural area to become full partners in managing their type 2 diabetes, and in the process bring changes to their community.
Site Logo
September 28th 2018

Welldoc Touts What Clinical Outcomes, Engagement Mean to Employers

Mary Caffrey
Employers who have been disappointed in the past with wellness programs want to see evidence of patient engagement and how this translates into savings.
Site Logo
September 28th 2018

Is It Time to Remodel Diabetes Self-Management Education and Support?

Hope S. Warshaw, MMSc, RD, CDE, BC-ADM
A former president of the American Association of Diabetes Educators addresses the need to remodel diabetes self-management education and support, to create a reimbursement system that better meets the needs of today's providers and patients.
Site Logo
September 28th 2018

In the Era of Payment Reform, Diabetes Educators Can Lead the Way Toward Value-Based Care

Robert Gabbay, MD, PhD, FACP
This article is based on a keynote presentation at the 2018 annual conference of the American Association of Diabetes Educators.
Dr Robert Gabbay: New Therapy Options Make It Easier to Manage Patients With Diabetes
September 28th 2018

Dr Robert Gabbay: New Therapy Options Make It Easier to Manage Patients With Diabetes

There are a growing number of diabetes therapies, which has led to the need to individualize choices based on patient profile, said Robert A. Gabbay, MD, PhD, FACP, senior vice president and chief medical officer of Joslin Diabetes Center.
This Week in Managed Care: September 28, 2018
September 28th 2018

This Week in Managed Care: September 28, 2018

This week, the top managed care news included comments to several proposals from CMS; Medicare advocates say voters will be motivated by healthcare cost concerns during the midterm elections; research showed diabetes drug dapagliflozin, an SGLT2 inhibitor, reduces risks of major cardiovascular events.
Diabetes Drug Farxiga Cuts Heart Risks in Topline Results
September 24th 2018

Diabetes Drug Farxiga Cuts Heart Risks in Topline Results

Mary Caffrey
Full results from the cardiovascular outcomes trial for dapagliflozin (Farxiga) will be presented at the American Heart Association annual meeting in November.
US Women Have Higher Risk of Dying Prematurely, Report Says
September 21st 2018

US Women Have Higher Risk of Dying Prematurely, Report Says

Allison Inserro
In the United States, a woman age 30 to 70 years of age has a 1 in 8 chance of dying from a noncommunicable disease (NCDs), putting the nation on par with low and middle-income countries, and setting it apart with Iceland among high-income countries, according to a report published Thursday in The Lancet.
Gene Curbs Obesity by Reducing Inflammation, Aiding Healthy Gut Bacteria
September 20th 2018

Gene Curbs Obesity by Reducing Inflammation, Aiding Healthy Gut Bacteria

Mary Caffrey
A series of experiments identified both "good" and "bad" gut bacteria, suggesting possible treatments for obesity.
A Multidisciplinary Approach to Managing Complexities in Cancer Care
September 19th 2018

A Multidisciplinary Approach to Managing Complexities in Cancer Care

As September marks National Ovarian Cancer Awareness Month, we sat down with ovarian cancer survivor Marion Roth and Vaagn Andikyan, MD, gynecologic oncologist, Western Connecticut Health Network, to discuss Marion's cancer journey and the importance of a multidisciplinary care team in treating complexities in cancer care.
Site Logo
September 14th 2018

Language Barriers and LDL-C/SBP Control Among Latinos With Diabetes

Alicia Fernandez, MD E. Margaret Warton, MPH Dean Schillinger, MD Howard H. Moffet, MPH Jenna Kruger, MPH Nancy Adler, PhD Andrew J. Karter, PhD
Among Latino patients with diabetes, ethnicity and language barriers were not associated with lipid and blood pressure control despite their associations with glycemic control in prior research. Check out our website’s new table/figure pop-up feature! Click on the name of a table or figure in the text to see it in your browser.
Review Outlines Algorithm for Managing Diabetes With Increased Fracture Risk
September 1st 2018

Review Outlines Algorithm for Managing Diabetes With Increased Fracture Risk

Alison Rodriguez
Fragility fractures are a serious complication of type 1 and type 2 diabetes, but many clinicians who treat patients with diabetes are not aware of the increased risk of these fractures.
Podcast: This Week in Managed Care—Next Gen ACO Success and Other Health News
September 1st 2018

Podcast: This Week in Managed Care—Next Gen ACO Success and Other Health News

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.
This Week in Managed Care: August 31, 2018
August 31st 2018

This Week in Managed Care: August 31, 2018

This week, the top managed care stories included encouraging results from the Next Generation Accountable Care Organization model; concerns that CMS' new billing rules will hurt the sickest patients; a study confirms the value of daily aspirin for patients with diabetes.
GLP-1 Drugs Not Associated With Increased Risk of Diabetic Retinopathy, Study Finds
August 29th 2018

GLP-1 Drugs Not Associated With Increased Risk of Diabetic Retinopathy, Study Finds

Mary Caffrey
The analysis of patient records found no elevated risk of retinopathy among those using glucagon-like peptide-1 (GLP-1) receptor agonists to treat type 2 diabetes.
ASCEND Results Confirm Aspirin Prevents Primary Vascular Events in Diabetes
August 27th 2018

ASCEND Results Confirm Aspirin Prevents Primary Vascular Events in Diabetes

Surabhi Dangi-Garimella, PhD
Serious vascular events in patients with diabetes can be prevented with aspirin use, according to results of the ASCEND (A Study of Cardiovascular Events iN Diabetes) trial, which were presented at the ongoing ESC Congress in Munich, Germany.
Site Logo
August 23rd 2018

Antihyperglycemic Medications for Cardiovascular Disease Risk Reduction

Jennifer D. Goldman, PharmD, RPh, CDE, BC-ADM, FCCP
Site Logo
August 23rd 2018

Economic Implications With Newer Agents to Reduce Cardiovascular Risk in Diabetes

Carrie McAdam-Marx, MSCI, PhD, RPh
Site Logo
August 23rd 2018

The Burden of Cardiovascular Disease in Patients with Diabetes

Brooke Hudspeth, PharmD, CDE
Site Logo
August 23rd 2018

From Diabetes Professional to Change Agent: The Shift That Population Health Requires

Mary Caffrey
A leader at the Institute for Healthcare Improvement offers a framework for diabetes educators to embrace a shift in thinking about healthcare delivery.
The Role of Technology in Preventing and Managing Diabetes
August 21st 2018

The Role of Technology in Preventing and Managing Diabetes

Given the high cost of treating diabetes and the large population with prediabetes, prevention has become a point of focus. We’re taking a look back to 2017, when The American Journal of Managed Care® convened a panel of experts to discuss diabetes prevention and the use of technology.
Dr Robert Gabbay Explains Controversy Over Recent A1C Guidelines
August 21st 2018

Dr Robert Gabbay Explains Controversy Over Recent A1C Guidelines

Robert A. Gabbay, MD, PhD, FACP, senior vice president and chief medical officer of Joslin Diabetes Center, explains why the Joslin Diabetes Center and the American Diabetes Association oppose the decision by the American College of Physicians to recommend a higher A1C target across the board.
Oral Semaglutide Offers Superior A1C Reduction, Weight Loss in PIONEER 5 Trial
August 20th 2018

Oral Semaglutide Offers Superior A1C Reduction, Weight Loss in PIONEER 5 Trial

Mary Caffrey
Patients with type 2 diabetes and moderate renal impairment who took oral semaglutide in a phase 3a trial reported a larger reduction in glycated hemoglobin and more weight loss than patients taking placebo.
Site Logo
August 19th 2018

Update on Diabetes Prevention Program Seeks Progress on Referrals, Reimbursement

Mary Caffrey
Three federal officials discussed the status of research, payer coverage, and referrals for the National Diabetes Prevention Program, as well as the rollout of the Medicare program for eligible seniors.
Site Logo
August 18th 2018

Finding the Golden Opportunity in Becoming a Diabetes e-Educator

Mary Caffrey
The rise of digital health alongside the transformation of reimbursement from fee-for-service to value-based care is allowing patients to fully participate in their own care, according to a leader with one of the top digital health companies in diabetes care.
Site Logo
August 17th 2018

Payment Reform Reveals Value of Diabetes Educators in Driving Down Healthcare Costs, Joslin's Gabbay Says

Mary Caffrey
Robert A. Gabbay, MD, PhD, FACP, chief medical officer and senior vice president at Joslin Diabetes Center, said health systems need people with the skill sets that diabetes educators possess to make the transition to a reimbursement system based on quality, prevention, and eliminating costs.
<1
...
232425262728293031
...
98>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo